Bret Blackhart, MD
Dermatology · Reno, NVNPI 1992708655
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,555 of the $6,747 with a category attached, or 67.5%. AbbVie accounts for 76.6% of it on its own, with 18 other manufacturers making up the rest.
Across 97 payments — averaging $69.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$276
- Incyte Corporation$250
- Genentech USA, Inc.$148
- Sun Pharmaceutical Industries Inc.$148
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$115
- plus $641 from 13 others
What the payments were for
- Speaking & faculty fees$4,55568%
- Food & beverage$1,95129%
- Education$2424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $5,170 |
| Johnson & Johnson | 5 | $276 |
| Incyte Corporation | 2 | $250 |
| Genentech USA, Inc. | 4 | $148 |
| Sun Pharmaceutical Industries Inc. | 4 | $148 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $115 |
| Strata Skin Sciences, Inc. | 5 | $108 |
| Sanofi | 4 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $92 |
| Novartis | 5 | $86 |
| Lilly USA, LLC | 2 | $44 |
| Amgen | 2 | $40 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Blueprint Medicines Corporation | 1 | $30 |
| LEO Pharma Inc. | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,747 in reported general payments places this provider in the 60th percentile of 78 dermatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cimzia (2 Pack)Certolizumab Pegol | 14 | $164,255 |
| Dupixent PenDupilumab | 25 | $105,089 |
| Humira(Cf) PenAdalimumab | 13 | $84,652 |
| Dupixent SyringeDupilumab | 11 | $40,061 |
| Calcipotriene-BetamethasoneCalcipotriene/Betamethasone | 14 | $9,831 |
| Clobetasol Propionate | 58 | $2,344 |
| Fluorouracil | 31 | $1,812 |
| Acitretin | 14 | $1,758 |
| Hydroxychloroquine Sulfate | 17 | $959 |
| Triamcinolone Acetonide | 138 | $935 |
| Ketoconazole | 33 | $712 |
| Doxycycline Hyclate | 24 | $677 |
| MethotrexateMethotrexate Sodium | 16 | $619 |
| Fluocinonide | 16 | $555 |
| Minocycline Hcl | 12 | $362 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Reno
- Laura OstezanReno$27K
- Diane SmithReno$16K
- William MortensenReno$13K
- Cindy LamersonReno$9K
- Gretchen KorverReno$8K
- Billie CasseReno$8K
- Brad HammonReno$7K
- Katherine MannoReno$6K
- Elizabeth CassinelliReno$5K
- Anne HayesReno$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.